Literature DB >> 26112755

Urinary Trypsin Inhibitor Attenuates Acute Lung Injury by Improving Endothelial Progenitor Cells Functions.

Weixin Guo1, Zhihong Li, Xiaoyun Xie, Tiehe Qin, Yan Wu, Zhou Li, Jing Chai, Frank Yi, Tao Tan, Hua Zhu, Shouhong Wang.   

Abstract

BACKGROUND: Urinary Trypsin Inhibitor (UTI) is involved in various aspects of tissue repair, regeneration and development. However, the potential role of UTI in protection against acute lung injury (ALI) remains largely unknown. In the present study, we demonstrated that UTI treatment could ameliorate ALI induced by oleic acid (OA) treatment in rabbit model.
METHODS: Intravenous application of UTI (10000 U/kg/d) significantly improved the pathologies associated with OA-induced ALI. The lungs were stained with hematoxylin and eosin to scored the lung injury. Peripheral blood mononuclear cells were isolated by density gradient centrifugation with Ficoll-Plaque Plus. The proliferation and ability of tube structure formation of EPCs were observed and the level of phosphorylated Akt protein expression and eNOS protein expression were assayed.
RESULTS: Consistent with pathological scores, UTI treatment significantly reduced wet/dry ratio of OA injured lungs. A quantification of capillary density revealed that UTI treatment led to about 2 fold increase over uninjured control and about 1.5 fold increase over PBS treatment. The capacity for tube formation of EPCs on ECM gel was significantly reduced in the ALI group and recovered with UTI treatment. Quantification of western blot bands was summarized and showed that UTI treatment activates Akt/eNOS signaling. NO production could contribute to the improvement of EPCs function by UTI treatment.
CONCLUSIONS: UTI-induced phosphorylation/activation of eNOS and Akt, increases the intracellular level of NO, thereby improving tube formation and proliferation function of EPCs. EPCs function is crucial for re-endothelialization after denuding injuries of arteries.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26112755     DOI: 10.1159/000430279

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  4 in total

1.  Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia.

Authors:  Poonam Sharma; Nikita Gaur; Shalini Jayant; B M Sharma; Bhagwat Singh; Harsha Kharkwal; Bhupesh Sharma
Journal:  Pharmacol Rep       Date:  2022-04-09       Impact factor: 3.024

2.  Blockade of NF-κB and MAPK pathways by ulinastatin attenuates wear particle-stimulated osteoclast differentiation in vitro and in vivo.

Authors:  Jiang-Ying Ru; Hai-Dong Xu; Dai Shi; Jun-Bo Pan; Xiao-Jin Pan; Yan-Fen Wang
Journal:  Biosci Rep       Date:  2016-10-27       Impact factor: 3.840

3.  Probucol protects circulating endothelial progenitor cells from ambient PM2.5 damage via inhibition of reactive oxygen species and inflammatory cytokine production in vivo.

Authors:  Yong Chen; Ke Hu; Haoran Bu; Zhihua Si; Haihui Sun; Liming Chen; Hang Liu; Hao Xie; Peng Zhao; Le Yang; Qinghua Sun; Zhenguo Liu; Lianqun Cui; Yuqi Cui
Journal:  Exp Ther Med       Date:  2018-09-24       Impact factor: 2.447

4.  Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia.

Authors:  Poonam Sharma; Prachi Kaushik; Swati Jain; Brij Mohan Sharma; Rajendra Awasthi; Giriraj Thirupathirao Kulkarni; Bhupesh Sharma
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-08-31       Impact factor: 2.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.